18F-氟胆碱PET/CT识别细胞学不确定甲状腺结节恶性:高敏感低特异
前瞻性纳入107例细胞学不确定且≥15mm需手术的甲状腺结节患者,行18F-氟胆碱PET/CT。病理金标准下恶性19例(18%)。PET/CT排除恶性敏感性高(90%/85%),但特异性低(50%/49%),阴性预测值达96%/94%。结论:FCH PET/CT可可靠排除PET阴性结节恶性,但阳性预测值低,尤其嗜酸细胞细胞学。
要点
- FCH PET/CT对细胞学不确定结节阴性预测值高,可辅助排除恶性。
- 特异性低,阳性预测值仅约29%,阳性结果需谨慎解读。
- 嗜酸细胞结节特异性更差(33% vs 非嗜酸细胞58%,p=0.01)。
核心结论
- FCH PET/CT对PET阴性细胞学不确定甲状腺结节有高阴性预测值,可可靠排除恶性,但阳性预测值低,尤其在嗜酸细胞细胞学结节中。
研究设计与样本
- 前瞻性研究,2016年5月至2019年3月纳入107例细胞学不确定且结节≥15mm、符合手术指征的患者,行头颈部FCH PET/CT(注射后20和60分钟采集),以病理为金标准。
主要发现
- 病理显示19例(18%)恶性,87例良性,1例为非侵袭性滤泡性甲状腺肿瘤伴乳头状核特征(NIFTP)。
- 20分钟时FCH PET/CT检测癌或NIFTP的敏感性90%、特异性50%、准确性55%、阳性预测值29%、阴性预测值96%;60分钟时分别为85%、49%、67%、28%、94%。
- 非嗜酸细胞结节(n=72)特异性高于嗜酸细胞结节(n=35)(58% vs 33%,p=0.01)。
- Bethesda III-IV结节中,PET/CT前癌或NIFTP概率为11%,PET阳性后为19%,PET阴性后为0%。
- 回顾性分析显示,PET/CT后42%的手术可避免,而PET/CT前为81%(p<0.001),假设减少48%(95%CI 32-64)。
临床怎么用
- 对于细胞学不确定的甲状腺结节,FCH PET/CT阴性可高置信度排除恶性,有助于减少不必要手术。
- PET/CT阳性结果因阳性预测值低,不应单独作为手术依据,需结合其他临床信息。
- 嗜酸细胞细胞学结节中FCH PET/CT特异性更低,解读阳性结果需格外谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Refining the risk of malignancy in patients presenting with thyroid nodules with indeterminate cytology (IC) is a critical challenge. We investigated the performances of 18F-fluorocholine (FCH) positron emission tomography/computed tomography (PET/CT) to predict malignancy. Methods: Between May 2016 and March 2019, 107 patients presenting with a thyroid nodule ≥15 mm with IC and eligible for surgery were included in this prospective study. Head-and-neck PET/CT acquisitions were performed 20 and 60 minutes after injection of 1.5 MBq/kg of FCH. PET/CT acquisition was scored positive when maximal standardized uptake value in the IC nodule was higher than in the thyroid background. Pathology was the gold standard for diagnosis. Results: At pathology, 19 (18%) nodules were malignant, 87 were benign, and one was a noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Sensitivity, specificity, accuracy, positive-predictive value (PPV), and negative-predictive value (NPV) of FCH PET/CT in detecting cancer or NIFTP were 90%, 50%, 55%, 29%, and 96% at 20 minutes and 85%, 49%, 67%, 28%, and 94% at 60 minutes, respectively. Higher specificity (58% vs. 33%, p = 0.01) was observed in nononcocytic (n = 72) than in oncocytic IC nodules (n = 35). The pre-PET/CT probability of cancer or NIFTP in Bethesda III-IV nodules was 11% and the post-PET/CT probability was 19% in PET-positives and 0% in PET-negatives. In retrospective analysis, 42% of surgeries would have been unnecessary after PET/CT and 81% before (p < 0.001), resulting in a hypothetical 48% reduction (95% confidence interval [32-64]). Conclusions: FCH PET/CT offers high NPV to reliably exclude cancer in PET-negative IC nodules, but suffers from low PPV, particularly in those with oncocytic cytology. ClinicalTrials.gov identifier: NCT02784223.
引用
- Ciappuccini R, Licaj I, Lasne-Cardon A, et al. 18F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study. Thyroid. 2020. PMID: 33183159. doi:10.1089/thy.2020.0555
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。